Labcorp EVP Kyle reports RSU vesting, tax shares

Labcorp Holdings Inc. executive Kathryn W. Kyle, EVP and Chief Legal Officer, reported equity award activity on February 11, 2026.

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Kathryn W. Kyle, EVP and Chief Legal Officer, reported equity award activity on February 11, 2026. She acquired 216 shares of common stock at $0 through the vesting and conversion of Restricted Stock Units, each representing one share of common stock. To cover tax withholding obligations, 62 shares of common stock were withheld at a price of $289.89 per share. After these transactions, she directly owned 3,442.4574 shares of common stock and 2,264 Restricted Stock Units in total.

Insider Trade Summary

216 shares exercised/converted

Exercise 3 txns

Insider Kyle Kathryn W

Role EVP, Chief Legal Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	216	$0.00	$0.00
Exercise	Common Stock	216	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	62	$289.89	$18K

Holdings After Transaction: Restricted Stock Unit — 2,264 contracts (Direct); Common Stock — 3,442.4574 shares (Direct)

Footnotes (4)

1. F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. F2. Stock withholding to satisfy tax withholding obligations.
3. F3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.
4. F4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Labcorp (LH) EVP Kathryn W. Kyle report?

Kathryn W. Kyle reported equity award activity involving Restricted Stock Units. On February 11, 2026, 216 Restricted Stock Units converted into 216 shares of Labcorp common stock at no cost, as part of a scheduled vesting from a prior grant.

How many Labcorp (LH) shares were withheld for taxes in this Form 4?

The filing shows 62 shares of Labcorp common stock were withheld. These shares were retained by the company at a price of $289.89 per share to satisfy Kathryn W. Kyle’s tax withholding obligations from the Restricted Stock Unit vesting event.

How many Labcorp (LH) common shares does Kathryn W. Kyle own after the transactions?

Following the reported transactions, Kathryn W. Kyle directly owned 3,442.4574 shares of Labcorp common stock. This number reflects her post-transaction direct holdings after both the 216-share RSU conversion and the 62-share tax withholding disposition.

How many Labcorp (LH) Restricted Stock Units does Kathryn W. Kyle hold after vesting?

After the vesting event, she held a total of 2,264 Restricted Stock Units. The filing explains this figure represents the aggregate number of Labcorp Restricted Stock Units that remain credited to her, separate from the common shares she holds directly.

What is the vesting schedule for Kathryn W. Kyle’s Labcorp Restricted Stock Units?

The vested Restricted Stock Units come from a grant that vests in three equal annual installments. The schedule begins on February 11, 2026, meaning additional units from this grant are expected to vest on the same calendar date in each of the next two years.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 01:10 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kyle Kathryn W

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		216	A	(1)	3,504.4574	D
Common Stock	02/11/2026		F(2)		62	D	$289.89	3,442.4574	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/11/2026		M			216	(3)	(3)	Common Stock	216	$0	2,264(4)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.